What sector does WHANIN PHARM CO.,LTD belong to?

WHANIN PHARM CO.,LTD operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 016580?

As of the latest available quote, 016580 traded at ₩10,300.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 016580?

WHANIN PHARM CO.,LTD has a price-to-earnings (P/E) ratio of about 14.00. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 016580?

The market capitalisation of WHANIN PHARM CO.,LTD is approximately ₩190.39B.

Is WHANIN PHARM CO.,LTD profitable?

For its latest reported financial year, WHANIN PHARM CO.,LTD recorded a net profit margin of about 5.33%.

Does 016580 pay a dividend?

WHANIN PHARM CO.,LTD currently has a dividend yield of about 2.58%.

What is the return on equity (ROE) of 016580?

WHANIN PHARM CO.,LTD has a return on equity (ROE) of about 3.23%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 016580?

Over the past 52 weeks, 016580 has traded between a low of ₩9,160.00 and a high of ₩12,140.00.

WHANIN PHARM CO.,LTD

016580 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩10,300.00

-0.29%

Delayed · cached 15 min

Fair value analysis

016580

WHANIN PHARM CO.,LTD

₩10,300.00

Close used for this calculation

₩12,649.94Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

57/100

Profitability10/25

Returns9/25

Balance Sheet20/25

Efficiency18/25

Growth14/25

Good

Quality radar

Consensus fair value

₩12,649.94

Below FV

▲ +22.8% against the close used

Model range ₩752.06 – ₩19,462.47

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩752.06Fair value₩12,649.94Bull₩19,462.47

FairClose

52-week traded range

52W low ₩9,230.0052W high ₩11,930.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

WHANIN PHARM CO.,LTD closed at ₩10,300.00, 18.6% below the consensus fair value of ₩12,649.94 drawn from 10 valuation models.

Financial DNA score 57/100 — Good. P/E of 14.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩13,785.32

+33.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩19,462.47

+89.0%

√(22.5 × EPS × BVPS)

EPS=735.51, BVPS=22888.89

Graham Formula

₩8,335.78

-19.1%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=0%, FD=3.3%

P/E Fair Value

₩14,710.20

+42.8%

EPS × 20x (sector P/E)

EPS=735.51, Sector P/E=20x

Peter Lynch (PEG)

₩3,751.10

-63.6%

EPS × Growth% (PEG = 1 is fair)

EPS=735.51, g=5.1%

EV/EBITDA

₩11,492.26

+11.6%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=21.24B

Dividend Discount (DDM)

₩3,388.19

-67.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=265.74, r=10%, g=2%

Book Value (P/B)

₩752.06

-92.7%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=22888.89, ROE=3.2%, g=3%, r=10%

Reverse DCF

₩10,300.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 2.3% | Historical: -5.1%

Margin of Safety

₩10,555.08

+2.5%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=14073.44, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer